home genetic news bioinformatics biotechnology literature journals ethics positions events sitemap


UBBFriend: Email This Page to Someone!
  HUM-MOLGEN
  Biotechnical requests and sources
  AnaSpec Launches New SensoLyte® Rh110 Long Wavelength Plasmin Activity Assay Kit

Post New Topic  Post A Reply
profile | register | preferences | faq | search

next newest topic | next oldest topic
Author Topic:   AnaSpec Launches New SensoLyte® Rh110 Long Wavelength Plasmin Activity Assay Kit
anaspec
Member
posted 03-12-2009 06:30 PM     Click Here to See the Profile for anaspec   Click Here to Email anaspec     Edit/Delete Message Reply w/Quote
San Jose, CA – March 12, 2009

AnaSpec, known for developing sensitive, long wavelength assays, is pleased to announce the release of another long wavelength protease assay – the SensoLyte® Rh110 Plasmin Activity Assay Kit (Ex/Em=496 nm/520 nm).

Plasmin is a serine protease derived from the conversion of plasminogen in blood plasma by plasminogen activators.1 Its primary function is to degrade fibrin in blood clots.1 Plasmin activators and inhibitors are thought to be the key participants in the balance between proteolytic and antiproteolytic activities that regulate extracellular matrix degradation.2 In addition to its established role in fibrinolysis, plasmin is also involved in several pathological and physiological processes such as embryogenesis, ovulation, inflammation, wound healing, angiogenesis, neoplasia, and metastasis.2

The SensoLyte® Rh110 Plasmin Assay Kit provides a convenient assay for screening of enzyme inhibitors and activators or for continuous assay of enzyme activity using a fluorogenic substrate. Upon plasmin protease cleavage, this substrate generates the Rh110 (rhodamine 110) fluorophore which has a bright green fluorescence and can be detected at Ex/Em=496 nm/520 nm. The longer-wavelength spectra and higher extinction coefficient of the Rh110 provide greater sensitivity and less interference from other reaction components.

About AnaSpec

AnaSpec is a leading provider of integrated proteomics solutions to the world’s largest biotech, pharmaceutical, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.

For more information visit www.anaspec.com
References
1. Collen, D. Circulation, 93, 857 (1996).
2. Vassalli, J.D. et al, J. Clin. Invest. 88, 1067 (1991).


###

IP: 12.236.16.122

All times are ET (US)

next newest topic | next oldest topic

Administrative Options: Close Topic | Archive/Move | Delete Topic
Post New Topic  Post A Reply
Hop to:

Contact Us | HUM-MOLGEN

Copyright by HUM-MOLGEN 1995-2015

Powered by: Ultimate Bulletin Board, Version 5.44a
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.